PSX
40
-4
NTRS
49
-5
IPG
39
-3
SWN
77
4
NAVI
55
-2
COST
56
3
VRTX
53
-2
ZTS
56
-2
ACN
56
13
PPG
61
-5
TXT
58
-2
PEG
76
5
PLD
51
-5
FCX
53
-5
SWKS
38
-2
CL
58
2
FOXA
48
7
SO
66
2
NKE
46
12
AEP
58
2
PSX
40
-4
NTRS
49
-5
IPG
39
-3
SWN
77
4
NAVI
55
-2
COST
56
3
VRTX
53
-2
ZTS
56
-2
ACN
56
13
PPG
61
-5
TXT
58
-2
PEG
76
5
PLD
51
-5
FCX
53
-5
SWKS
38
-2
CL
58
2
FOXA
48
7
SO
66
2
NKE
46
12
AEP
58
2
Financhill
Back

Accuray Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
37

ARAY
Accuray

Last Price:
1.73
Seasonality Move:
4.48%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
37
Accuray (ARAY) is a Sell

Is Accuray a Buy, Sell or Hold?

  • The current Accuray [ARAY] share price is $1.72. The Score for ARAY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • ARAY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ARAY Stock Price Chart

What is Accuray's stock price today?

  • The Accuray share price today is $1.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARAY is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

ARAY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 38.34 Sell
Chaikin Money Flow: -1799155 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.94 - 2.3) Sell
Bollinger Bands (100): (1.59 - 2.07) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

ARAY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.98 Sell
20-day SMA: 2.07 Sell
50-day SMA: 1.94 Sell
200-day SMA: 2.22 Sell
8-day EMA: 1.93 Sell
20-day EMA: 2 Sell
50-day EMA: 1.96 Sell
200-day EMA: 2.18 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Accuray Earnings Growth & ARAY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.15 per share, and an increase next year of $0.14 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Accuray Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):